Section 1: Active/Recruiting Studies.- Section 1, Part 1: Retina/Optic Nerve.- Chapter 1: United States.- Chapter 2: Belarus.- Chapter 3: Caribbean/Latin America.- Chapter 4: China.- Chapter 5: Great Britain.- Chapter 6: Indonesia.
- Chapter 7: Japan.- Chapter 9: Turkey.- Section 1, Part 2: Anterior Segment.- Chapter 10: United States.- Chapter 11: Canada.- Chapter 12: China.- Chapter 13: France.- Chapter 14: Spain.
- Section 2: Active, Non-recruiting Studies.- Section 2, Part 1: Retina/Optic Nerve.- Chapter 15: United States.- Chapter 16: No Location.- Section 2, Part 2: Anterior Segment.- Chapter 17: United States.- Chapter 18: Germany.- Chapter 19: Denmark.
- Chapter 20: France.- Chapter 21: Spain.- Section 3: Completed Studies.- Section 3, Part 1: Retina/Optic Nerve.- Chapter 22: United States.- Chapter 23: Brazil.- Chapter 24: Turkey.- Section 3, Part 2: Anterior Segment.
- Chapter 25: United States.- Chapter 26: Belarus.- Chapter 27: Iran.- Chapter 28: Korea.- Chapter 29: Spain.- Section 4: Unknown Status.- Chapter 30: Belgium.- Chapter 31: Brazil.
- Chapter 32: China.- Chapter 33: Egypt.- Chapter 34: India.- Chapter 35: Jordan.- Chapter 36: Korea.- Chapter 37: Lebanon.- Chapter 38: Malaysia.- Chapter 39: Poland.
- Chapter 40: Spain.- Chapter 41: Taiwan.- Chapter 42: Thailand.- Section 5: Withdrawn Studies.- Chapter 43: United States.- Chapter 44: China.- Section 6: Terminated Studies.- Chapter 45: United States.
- Chapter 46: Iran.- Section 7: Suspended Studies.- Chapter 47: Singapore.- Section 8: Analysis.- Chapter 48: Analysis of studies.- Chapter 49: Comments.